Gpx2, one of three glutathione peroxidase homologues (Gpx1, Gpx2, and Gpx3) in Saccharomyces cerevisiae, is an atypical 2-Cys peroxiredoxin that prefers to use thioredoxin as a reducing agent in vitro. Despite Gpx2 being an antioxidant, no obvious phenotype of gpx2∆ mutant cells in terms of oxidative stress has yet been found. To gain a clue as to Gpx2's physiological function in vivo, here we identify its intracellular distribution. Gpx2 was found to exist in the cytoplasm and mitochondria. In mitochondria, Gpx2 was associated with the outer membrane of the cytoplasmic-side, as well as the inner membrane of the matrix-side. The redox state of the mitochondrial Gpx2 was regulated by Trx1 and Trx2 (cytoplasmic thioredoxin), and by Trx3 (mitochondrial matrix thioredoxin). In addition, we found that the disruption of GPX2 reduced the sporulation efficiency of diploid cells.
Introduction
All organisms take up organic compounds from the environment, and derive electrons from such compounds to regenerate reductive coenzymes for energy production. In particular, aerobic organisms use molecular oxygen (O 2 ) as the final acceptor of electrons at the final step in the electron transfer system for ATP production. O 2 accepts four electrons one by one, and consequently, several intermediates are generated. O 2 per se is a biradical, but it is not as reactive as the intermediates generated during the reduction of O 2 , which in turn are referred to as reactive oxygen species. Hence, for all aerobic organisms, it is unavoidable that reactive oxygen species are generated during energy production. Organisms of all types are armed with several antioxidant systems. For example, one-electron-reduction of O 2 by peroxidases with different electron donors. Generally, peroxidases are named according to the electron donors that they use, e. g. ascorbate peroxidase, glutathione peroxidase, and thioredoxin peroxidase. We have previously reported that the budding yeast Saccharomyces cerevisiae has three glutathione peroxidase (GPx) homologues (Gpx1, Gpx2, and Gpx3) [1] .
Peroxiredoxins (Prxs) are ubiquitous antioxidants in all types of organisms [2] , which are characterized by certain common properties in that they do not contain a redox active cofactor or prosthetic group, and contain conserved Cys residue(s). According to the number of conserved Cys residues, Prxs are divided into two major groups, i.e. 1-Cys Prx and 2-Cys Prx.
In both Prxs, the N-terminal Cys, which is sometimes referred to as the peroxidatic Cys, is conserved. In 2-Cys Prx, another Cys residue that is referred to as the resolving Cys is conserved, and two intermolecular disulfide bonds are formed between the peroxidatic Cys and resolving Cys as a consequence of the reduction of peroxides, and subsequently a Prx dimer is formed. Meanwhile, in a family of atypical 2-Cys Prxs, an intramolecular disulfide bond is formed within the same molecule. We have previously reported that Gpx1 and Gpx2 are atypical 2-Cys peroxiredoxins using both glutathione and thioredoxin as regucing agents [3, 4] , while Delaunay et al. [5] have reported that Gpx3 shows thioredoxin peroxidase activity in
vitro.
Since the expression of GPX3 is constitutive, and besides being an antioxidant, Gpx3
functions as a redox sensor and transducer of the oxidative stress-responsive transcription factor
Yap1 [5] , gpx3∆ mutant cells exhibit a clear phenotype in terms of the loss of the antioxidant [1] . Meanwhile, even though Gpx1 and Gpx2 show peroxidase activity in vitro [3, 4] , neither
gpx1∆ nor gpx2∆ cells demonstrate any obvious phenotypes in terms of oxidative stress [1] . To gain a clue as to Gpx2's physiological function in vivo, we determined its intracellular localization. Here we show that Gpx2 is distributed in both the cytoplasm and mitochondria. We explored the roles of Gpx2 with respect to mitochondria, and found that Gpx2 is involved in the process of sporulation, i. e. the loss of Gpx2 decreased the sporulation efficiency of diploid cells.
Materials and methods

Strains and media
The S. cerevisiae strains used in this study are summarized in Supplemental Table1.
Cells were grown in YPD medium (2% glucose, 1% yeast extract, and 2% peptone), or synthetic dextrose (SD) medium (2% glucose, 0.67% yeast nitrogen base without amino acid) with appropriate amino acids and bases at 28ºC. For peroxide treatment, 0.4 mM H 2 O 2 was added to the culture, in which logarithmically growing cells are involved, and incubated for 60 min. and fmp45∆::LEU2 strains, PCR was performed with primers Fmp45-F and Fmp45-R using pUC19-fmp45∆::URA3 or pUC19-fmp45∆::LEU2 as a template, and the amplified fragment was introduced into YPH250 and YPH252, respectively.
Gene disruption
Western blotting
After SDS-polyacrylamide gel electrophoresis (SDS-PAGE), separated proteins were transferred to a PVDF membrane (Immobilon, Millipore). To detect proteins of interest, antibodies for each protein [anti-Gpx2 [4] , anti-Por1 (Cell Signaling), anti-Dpm1 (Cell Signaling), anti-Pgk1 (Cell Signaling), anti-Tom70 [7] , anti-Tim50 [7] , and anti-Hsp60 [7] antibodies] were used. Anti-rabbit IgG conjugated with alkaline phosphatase (Cell Signaling) was used as the secondary antibody, and the immunoreacted bands were visualized with a BCIP-NBT kit (Nacalai tesque).
Subcellular fractionation
The subcellular fractionation experiment, and sucrose density gradient ultracentrifugation was done essentially as described by Meisinger et al. [8] . Details as to the experimental conditions are described in the Supplemental Materials and methods.
Determination of submitochondrial localization of Gpx2
Treatment of mitochondria with proteinase K, NaCl, sonication, and Na 2 CO 3 to determine the localization of proteins was done essentially as described by Yamamoto et al. [9] .
Details as to the experimental conditions are described in the Supplemental Materials and methods.
Determination of the redox states of mitochondrial Gpx2
The modification of Cys residues of Gpx2 was performed basically as described by Tanaka et al. [4] . added to adjust the pH of the sample, and the mixture was boiled for 2 min. Twenty microliters of the sample was subjected to non-reducing SDS-PAGE followed by Western blotting using anti-Gpx2 antibody to determine the redox state of Gpx2 in mitochondria.
Determination of sporulation efficiency
Diploid cells grown for 1 day on YPD agar plates were suspended in a 0.85% NaCl solution, and diluted with a 0.85% NaCl solution to bring the A 610 to 0.1. The cell suspension was spotted in quintuplicate (5 µl each) onto plates containing sporulation medium (1% potassium acetate, 0.1% yeast extract, 0.05% glucose, 2% agar, and appropriate amino acids), and incubated at 25ºC. On each day of incubation, all the cells of one of five spots were recovered, and suspended in the 0.85% NaCl solution. The numbers of sporulated cells forming spores were counted using a microscope.
Results
Gpx2 is distributed in both mitochondria and cytoplasm
Though Gpx2 is an atypical 2-Cys Prx that prefers to use thioredoxin as a reducing agent in vitro [4] , gpx2∆ cells do not exhibit any obvious phenotype regarding peroxide sensitivity. To gain insights into its function in vivo, we tried to determine the subcellular localization of Gpx2. We found that Gpx2 was present in not only soluble fractions but also insoluble fractions, so it is feasible that Gpx2 exists in some organelles. To address this possibility, we fractionated cell homogenates by a subsequent centrifugation, and found that Gpx2 was predominantly located in the crude mitochondrial fractions (P13) and in the cytoplasmic fractions (S13) (Fig. 1A) . In H 2 O 2 -treated cells, the overall Gpx2 level was increased as reported previously [1] , and Gpx2 was detected in both the crude mitochondria and cytoplasm ( Fig. 1A ).
In the preparation of mitochondria by centrifugation, the ER contaminates the crude mitochondrial fractions. As shown in Fig. 1A , both Por1 (mitochondrial marker protein) and Dpm1 (ER marker protein) were detected in the crude mitochondrial fractions (P13). Therefore, to eliminate the ER, these samples were subjected to a three-step sucrose density gradient ultracentrifugation. As shown in Fig. 1B , the pattern of fractionation of Gpx2 coincided with that of Por1 but not Dpm1. Therefore, Gpx2 is likely to be located in both mitochondria and the cytoplasm in yeast cells.
Submitochondrial localization of Gpx2
Next, we determined the submitochondrial localization of Gpx2. Mitochondria were treated with proteinase K (PK). The principle of this experiment is as follows: in whole mitochondria, PK can digest only proteins associated with the surface of mitochondria; in mitoplasts, PK can also digest proteins in the intermembrane space and those associated with the surface of the inner membrane facing the intermembrane space; and in solubilized mitoplasts, PK can also digest proteins in the matrix. As shown in Fig. 2A , when whole mitochondria were treated with PK, Tom70, an outer membrane-integrated protein, was digested completely, because a large part of Tom70 is exposed at the surface of the mitochondrial outer membrane. However, approximately half of the mitochondrial Gpx2 was not digested under the same conditions. These results imply that some Gpx2s seem to exist on the surface of the outer membrane of mitochondria, but the rest are likely to be sequestered in mitochondria where PK cannot reach. Next, when mitoplasts were treated with PK, Gpx2 still remains within the mitoplasts, which implies that Gpx2 exists neither in the intermembrane space nor on the surface of the inner membrane facing the intermembrane space. In the PK treatment of solubilized mitoplasts, the rest of the Gpx2s were digested, a pattern which resembles Hsp60, a matrix marker protein. Therefore, Gpx2 seems to exist in the matrix also.
Gpx2 is associated with the surface of mitochondrial membranes via ionic interaction
To further explore the mode of existence of Gpx2 in the submitochondrial compartment, we treated mitochondria with NaCl, sonication, and Na 2 CO 3 . As shown in Fig. 2B , some Gpx2 was released from whole mitochondria to the supernatant fractions after treatment with 0.5 M NaCl for 60 min. However, Tom70 was not released from whole mitochondria under the same conditions, because this protein is integrated in the outer mitochondrial membrane. This result indicates that Gpx2 is not a membrane-integrated protein, but associated with the outer membrane through the ionic interaction.
Sonication disrupts the mitochondrial membrane. After sonication, the disrupted mitochondria were centrifuged. As a result, Gpx2 was mainly detected in the precipitates (Fig.   2B ). This behavior in terms of protein localization resembles that of Tom70 and Tim50, integrated in the outer and inner membrane of mitochondria, respectively; but is different from that of Hsp60, a soluble protein in the matrix. This result also indicates that Gpx2 is a membrane-associated protein.
Na 2 CO 3 also destroys mitochondria. After centrifugation of the NO 2 CO 3 -treated mitochondria, Gpx2 was mainly detected in the supernatants. This behavior resembles that of Tam41 (data not shown), a peripheral membrane protein [10] , but is different from that of Tom70 and Tim50, membrane-integrated proteins (Fig. 2B ). This result indicates that Gpx2 is a peripheral membrane protein not a membrane-integrated protein. Taken together, Gpx2 is a peripheral protein positioned on the outer membrane of mitochondria facing the cytoplasm via ionic interaction, as well as on the inner membrane facing the matrix.
Redox regulation of mitochondrial Gpx2
Previously, we have shown that the redox state of the bulk cellular Gpx2 is predominantly regulated by Trx1 and Trx2 (cytoplasmic thioredoxin) [4] . Here, we focused on the redox regulation of mitochondrial Gpx2. The redox state of mitochondrial Gpx2 was determined by the AMS modification assay. As shown in Fig. 3 [1, 12] ; and therefore, Yap1 is constitutively activated in the trx1∆trx2∆ mutant, thereby enhancing GPX2 expression.
Effects of GPX2's disruption on sporulation
Comprehensive analyses of the physical interactions of yeast proteins have been conducted using different analytical methods. It has been reported that Gpx2 physically interacts with several proteins. Since we have demonstrated that Gpx2 is distributed in mitochondria, we focused on Fmp45, a mitochondrial membrane-integral protein. Tarassov et al. [13] revealed the physical interaction between Gpx2 and Fmp45 in vivo with a protein-fragment complementation assay. It has been reported that a deficiency in Fmp45 reduces sporulation efficiency [14] . We confirmed that the sporulation efficiency of fmp45∆/fmp45∆ diploid cells was reduced (Fig. 4) .
So, we determined the effect of the loss of Gpx2 on the sporulation efficiency of diploid cells.
As shown in Fig. 4 , the sporulation efficiency of gpx2Δ/gpx2Δ cells was decreased compared with that of GPX2/GPX2 cells, whose rate was comparable to that of fmp45∆/fmp45∆ cells.
Next, we determined whether any correlation between Gpx2 and Fmp45 exists in terms of the reduction in sporulation efficiency. The sporulation efficiency of the fmp45∆gpx2∆/fmp45∆gpx2∆ mutant did not decrease further compared with that of the fmp45∆/fmp45∆ cells (Fig. 4) .
Discussion
The cellular localization of a protein provides a powerful hint as to its function.
Previously, we have tried to determine the subcellular distrubution of Gpx2 using a GFP-tagged Gpx2, and found that the fluorescence derived from Gpx2-GFP was observed as punctate foci scattered within the cell (Tsuzi, D., Maeta, K., Izawa, S., and Inoue, Y., unpublished results);
however, direct evidence that Gpx2 exists in distinctive organelles has not been obtained.
Additionally, since the gpx2∆ mutant did not exhibit obvious phenotypes, it is difficult to verify whether GFP-tagged Gpx2 is correctly distributed in the cell and functioning properly through complementation of the mutant's phenotype. Here, we adopted biochemical approaches to determine the localization of Gpx2.
We have demonstrated that Gpx2 is present in both the cytoplasm and mitochondria.
The mitochondrial Gpx2 shows a characteristic distribution, i. e. some is associated with the surface of the outer membrane on the cytoplasmic-side, while the rest is associated with the surface of the inner membrane on the matrix-side. Considering the results of biochemical analyses, Gpx2 seems to be recruited to the mitochondrial outer membrane through ionic interaction (Fig. 2B) . The pI value of Gpx2 is calculated to be 8.8 based on its amino acid sequence, therefore, Gpx2 is likely to be positively charged at a physiological pH, which may enable this protein to associate with the mitochondrial membranes that are negatively charged due to phosphorus groups of phospholipids. We found that Gpx2 carrying an HA-tag at the C terminus, which has a lower pI (5.5) value, was not properly localized to mitochondria (Supplemental Fig. S1 ). Since Gpx2-HA is supposed to be negatively charged at a physiological pH, the ionic interaction with the mitochondrial membrane might have been inhibited. Hence, the positive charge of Gpx2 might be one of the factors that enable this protein to attach to the mitochondrial outer membrane. In addition, Gpx2 does not have the predicted signal sequence at the N terminus for translocation into mitochondria. Indeed, the apparent molecular weight of the mitochondrial Gpx2 was the same as that of the cytoplasmic protein. In addition, the Gpx2 protein carrying a FLAG-tag at the N terminus was properly translocated to mitochondria with Western blotting using anti-FLAG antibody (Supplemental Fig. S1 ), and therefore, the processing of the N terminus is not likely to occur during the translocation of Gpx2 into mitochondria. Hence, the mechanism by which Gpx2 is translocated into the mitochondrial matrix is of considerable interest.
Avery and Avery [15] have reported that Gpx2 is active toward phospholipid hydroperoxide in vitro. Among mammalian GPxs, only PHGPx/GPx4 (phospholipid hydroperoxide GPx) is able to attack glycerophosphate hydroperoxides, and Gpx2 is the orthologue of PHGPx/GPx4 [4] . Therefore, it is feasible that Gpx2 protects the integrity of the mitochondrial membrane by preventing the peroxidation of phospholipids. On the other hand, Entian et al. [16] complex [19] [20] [21] . In addition, if Gpx2 functions as an antioxidant to reduce phospholipid hydroperoxides in the mitochondrial membrane, its loss may reduce the integrity of the mitochondrial membrane to decrease the efficiency of mitochondrial membrane docking.
However, since it is difficult to quantitate the change of mitochondrial morphology, we need to define an index to evaluate the morphological change of mitochondria.
In addition to the cellular localization of proteins, the physical and/or genetic interaction among gene products whose the functions are known would provide a clue as to the related physiological role of a function-unknown partner. Fmp45 is a mitochondrial membrane-integral protein, and involved in the process of sporulation. It has been reported that Fmp45 physically interacts with Gpx2 [13] . Considering that Gpx2 is associated with the mitochondrial membrane, it is feasible that these proteins share some functions in mitochondria.
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Subcellular fractionation
The subcellular fractionation experiment was done essentially as described by Meisinger et al. [1] with slight modifications. Cells grown to a log phase of growth were treated with 4 mg/ml Zymolyase-100T (Seikagaku Kogyo Co.) in potassium phosphate buffer (pH 7.4) containing 1.2 M sorbitol at 30ºC for 60 min to obtain spheroplasts. After the homogenization of spheroplasts by 30 strokes in a Dounce glass homogenizer in 15 ml of ice-cold homogenization buffer [0.6 M sorbitol, 10 mM Tris-HCl (pH 7.4), 1 mM EDTA, and 1 mM phenylmethyl sulfonyl fluoride (PMSF)], cell debris and nuclei were removed by centrifugation at 1500 x g for 5 min. The supernatants were centrifuged at 1800 x g for 10 min twice, and the resultant supernatants were further centrifuged at 13000 x g for 10 min to precipitate crude mitochondria. The crude mitochondrial pellets were washed with SEM buffer [250 mM sucrose, 1 mM EDTA, and 10 mM MOPS (pH 7.2)], and again centrifuged at 13000 x g for 10 min. The resulting crude mitochondrial fractions (P13) were then resuspended in SEM buffer to give a final concentration of 1 mg of protein per ml. To prepare the cytoplasmic fraction, the supernatants after the preparation of crude mitochondria (S13), were centrifuged at 100000 x g for 20 min. The resultant supernatants were S100 fractions, and the resultant precipitates were P100 fractions. Each fraction was subjected to SDS-PAGE followed by Western blotting using respective antibodies to verify the localization of marker proteins.
To separate ER from the crude mitochondrial fractions, the crude mitochondria (250 µg protein) in 250 µl of SEM buffer were loaded onto the top of a three-step sucrose density gradient [0.75 ml 60%, 2 ml 32%, 0.75 ml 23%, 0.75 ml 15% (w/v) sucrose in EM buffer (10 mM MOPS, pH 7.2, and 1 mM EDTA)]. The centrifugation was done at 134000 x g for 1 h at 2ºC with a RPS40-T rotor (himac CP75β, Hitachi Koki). Each fraction (500 µl) was collected from the top of the tube (9 fractions), and proteins were precipitated by adding 125 µl of 100% trichloroacetic acid (TCA). The mixture was centrifuged at 13000 x g for 10 min at 4ºC, and the precipitates were washed once with acetone. After removal of the acetone, the dried materials were suspended in 40 µl of 1 M Tris solution. The suspension was mixed with 10 µl of 5x sample buffer, and the mixture was boiled for 5 min. The sample was subjected to SDS-PAGE followed by Western blotting.
Proteinase K treatment
Treatment of mitochondria with proteinase K to determine the localization of proteins was done essentially as described by Yamamoto et al. [2] with slight modifications. Briefly, the crude mitochondria (200 µg protein) were suspended in 200 µl of TS buffer [0.6 M sorbitol, and 10 mM Tris-HCl (pH 7.4)]. Mitoplasts were generated with osmotic swelling by suspending the crude mitochondria (200 µg protein) in a 10-fold volume of 10 mM Tris-HCl (pH 7.4) buffer for 20 min on ice. The mitoplasts were collected by centrifugation at 13000 x g for 10 min, and suspended in 200 µl of TS buffer. Solubilized mitoplasts were generated from the mitoplasts (200 µg protein) by treatment with 0.1% Triton-X100 in 200 µl of TS buffer for 20 min on ice. Each suspension of crude mitochondria, mitoplasts, and solubilized mitoplasts was treated with 10-50 µg/ml of proteinase K (Wako) for 30 min on ice. The reaction was stopped by addition of 1 mM PMSF for 5 min on ice, and 50 µl of 100% TCA was added. The precipitates were washed once with acetone. After removal of the acetone, the dried materials were suspended with 32 µl of 1 M Tris solution. The suspension was mixed with 8 µl of 5x sample buffer, and the mixture was boiled for 5 min. The sample was subjected to reducing SDS-PAGE followed by Western blotting.
NaCl, sonication, and Na 2 CO 3 treatment
Treatment of mitochondria with NaCl, sonication, and Na 2 CO 3 to determine the localization of proteins was done essentially as described by Yamamoto et al. [2] with slight modifications. Briefly, the crude mitochondria (200 µg protein) were treated in 200 µl of 0.5 M NaCl or 0.1 M Na 2 CO 3 in TS buffer containing 1 mM PMSF for 30 min on ice. Mitoplasts (2 mg of protein) prepared by hypo-osmotic swelling as described previously were treated with sonication (50 W, 15 sec, 3 sets) in 2 ml of TS buffer. Each solution was centrifuged at 100000 x g for 30 min at 4ºC. The precipitates were suspended in 32 µl of 1 M Tris solution, and the suspension was mixed with 8 µl of 5x sample buffer. The supernatants were mixed in 50 µl of 100% TCA, the mixture was centrifuged at 13000 x g for 10 min at 4ºC, and the precipitates were washed once with acetone. After removal of the acetone, the dried materials were suspended with 32 µl of 1 M Tris solution. The suspension was mixed with 8 µl of 5x sample buffer, and the mixtures were boiled for 5 min. The sample was subjected to SDS-PAGE followed by Western blotting.
